Literature DB >> 24477344

The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis.

Brad D Pearce1, Deanna Kruszon-Moran, Jeffrey L Jones.   

Abstract

PURPOSE: To examine the relationship between infection with Toxoplasma gondii (toxo) and cognition.
METHODS: Multivariate logistic regression was used to test the association of toxo seropositivity with indices of cognitive function among over 4,200 adults in the third National Health and Nutrition Examination Survey.
RESULTS: Toxo-seropositive participants were more likely than seronegative participants to score in the worst quartile of the simple reaction time test (OR 1.3, 95 % CI 1.0, 1.6), symbol-digit substitution test (SDST, OR 1.5, 95 % CI 1.2, 1.9) and the serial-digit learning test (trials to criterion) (SDLTNT, OR 1.4, 95 % CI 1.1, 1.8) in models adjusted for age, race/ethnicity, gender and foreign birth. After further adjustment for all cofactors, the association between toxo seropositivity and these outcomes was no longer significant. However, seropositivity was associated with worse scores on the SDST (OR 2.9, 95 % CI 1.8, 4.8) among those in the lowest income category and the SDLTNT (OR 1.5, 95 % CI 1.1, 2.5) among those foreign born.
CONCLUSIONS: Toxo seropositivity may be associated with poor cognitive test scores in certain subgroups; however, causation cannot be established in this cross-sectional study.

Entities:  

Mesh:

Year:  2014        PMID: 24477344      PMCID: PMC4091920          DOI: 10.1007/s00127-014-0820-5

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  33 in total

1.  Neurobehavioral test performance in the third National Health and Nutrition Examination Survey.

Authors:  E F Krieg; D W Chrislip; R E Letz; D A Otto; C J Crespo; W S Brightwell; R L Ehrenberg
Journal:  Neurotoxicol Teratol       Date:  2001 Nov-Dec       Impact factor: 3.763

2.  Transient nature of Toxoplasma gondii-induced behavioral changes in mice.

Authors:  S Hrdá; J Votýpka; P Kodym; J Flegr
Journal:  J Parasitol       Date:  2000-08       Impact factor: 1.276

3.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

5.  Toxoplasmosis and mental retardation--report of a case-control study.

Authors:  W T Caiaffa; C A Chiari; A R Figueiredo; F Orefice; C M Antunes
Journal:  Mem Inst Oswaldo Cruz       Date:  1993 Apr-Jun       Impact factor: 2.743

6.  Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Jian Zhang; Matthew F Muldoon; Robert E McKeown
Journal:  Am J Clin Nutr       Date:  2004-08       Impact factor: 7.045

7.  Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis?

Authors:  Jaroslav Flegr; Marek Preiss; Jirí Klose; Jan Havlícek; Martina Vitáková; Petr Kodym
Journal:  Biol Psychol       Date:  2003-07       Impact factor: 3.251

8.  Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III).

Authors:  Valory N Pavlik; David J Hyman; Rachelle Doody
Journal:  Neuroepidemiology       Date:  2004-09-24       Impact factor: 3.282

9.  Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey.

Authors:  May A Beydoun; Hind A Beydoun; Monal R Shroff; Melissa H Kitner-Triolo; Alan B Zonderman
Journal:  Psychosom Med       Date:  2013-05-22       Impact factor: 4.312

10.  Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study.

Authors:  Jaroslav Flegr; Jan Havlícek; Petr Kodym; Marek Malý; Zbynek Smahel
Journal:  BMC Infect Dis       Date:  2002-07-02       Impact factor: 3.090

View more
  18 in total

1.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Luis-Miguel Ortega-Mora; Javier Moreno-Gonzalo; Ignacio Ferre; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Lynn K Barrett; Dustin J Maly; Kayode K Ojo; Wes Van Voorhis; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

2.  Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population.

Authors:  Nick M Massa; Erica Duncan; Tanja Jovanovic; Kimberly Kerley; Lei Weng; Lauren Gensler; Samuel S Lee; Seth Norrholm; Abigail Powers; Lynn M Almli; Charles F Gillespie; Kerry Ressler; Bradley D Pearce
Journal:  Brain Behav Immun       Date:  2016-11-21       Impact factor: 7.217

Review 3.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

4.  Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection.

Authors:  L Ene; T D Marcotte; A Umlauf; C Grancea; A Temereanca; A Bharti; C L Achim; S Letendre; S M Ruta
Journal:  J Neuroimmunol       Date:  2016-08-04       Impact factor: 3.478

5.  Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample.

Authors:  Ibtihal Ibrahim; Hala Salah; Hanan El Sayed; Hader Mansour; Ahmed Eissa; Joel Wood; Warda Fathi; Salwa Tobar; Ruben C Gur; Raquel E Gur; Faith Dickerson; Robert H Yolken; Wafaa El Bahaey; Vishwajit Nimgaonkar
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

6.  The association of Toxoplasma gondii IgG and cognitive function scores: NHANES 2013-2014.

Authors:  R Constance Wiener; Christopher Waters; Ruchi Bhandari
Journal:  Parasitol Int       Date:  2020-05-13       Impact factor: 2.230

7.  Interaction between Helicobacter pylori and latent toxoplasmosis and demographic variables on cognitive function in young to middle-aged adults.

Authors:  Shawn D Gale; Lance D Erickson; Bruce L Brown; Dawson W Hedges
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

Review 8.  Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection.

Authors:  Ellen Tedford; Glenn McConkey
Journal:  Pathogens       Date:  2017-05-17

9.  Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer's disease in wild-type, C57BL/6 mice.

Authors:  Luisa Torres; Sudie-Ann Robinson; Do-Geun Kim; Angela Yan; Thomas A Cleland; Margaret S Bynoe
Journal:  J Neuroinflammation       Date:  2018-02-23       Impact factor: 8.322

10.  Lower performance of Toxoplasma-infected, Rh-negative subjects in the weight holding and hand-grip tests.

Authors:  Jaroslav Flegr; Blanka Šebánková; Lenka Příplatová; Veronika Chvátalová; Šárka Kaňková
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.